News Releases

Bodisen Biotech Launches New Product, Expands into Agricultural Raw Materials Market, Bodisen Sees Strong Customer Demand
Monday February 13, 8:00 am ET

Bodisen Builds Capacity to Become One of the Largest Producers of Mancozeb

NEW YORK--(BUSINESS WIRE)--Feb. 13, 2006--Bodisen Biotech, Inc., (AMEX:BBC, London AIM:BODI, website: /) the first China based environmentally friendly bio fertilizer company listed on a US stock exchange, today announced the launch of its new pesticide raw materials production line which is expected to make Bodisen one of the largest producers of Mancozeb in China.

Mancozeb, an essential agricultural raw material for pesticide, has been in high demand amongst farmers worldwide. Mancozeb is the most versatile chemical used in the production of fungicides due to the fact that it can also be utilized as an end product on crops and not just as a raw material. Bodisen's state of the art facility, which is expected to be completed in March 2006, will employ some of the most current agricultural technologies available. The new manufacturing facility gives Bodisen a competitive advantage, which it believes will increase its production density up to 20% higher than its competitors, making Bodisen an emerging leader in China's agricultural and raw materials markets.

Ms. Karen Qiong Wang, CEO of Bodisen commented, "This is the beginning of Bodisen's entry into the highly profitable agricultural raw materials business. It is a natural vertical integration of Bodisen's existing product lines since we already have some of the best agricultural product distribution channels that exist in China. Demand for this new product from our distribution channels throughout China has been very strong and we see it as one of our future growth catalysts for our business. The launch of this new product line will further strengthen Bodisen's leadership position as one of the fastest growing companies in China."

Ms. Wang continued: "With the completion of our recent financing in London, Bodisen is in a strategic position to continue to aggressively grow our business even further into new markets and new product lines. Our planned two new facilities located in the northeast and northwest parts of China will each have the same production capacity and sales growth as our existing facilities. This is a testament to the strong demand we have and continue to see and we are excited to be able to execute on our strategic growth initiatives in meeting this growing demand and generating long term returns for our growing shareholder base."

In January 2006, Forbes Magazine ranked Bodisen the 16th fastest growing company in China.

About Bodisen Biotech, Inc.

A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. The Bodisen brand is a highly recognized agricultural product brand in China that is known for fertilizer products that generate higher yields for farmers. Bodisen's environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into 3 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; and Pesticides & Insecticides. Bodisen's organic fertilizers can be absorbed by plants within 48 hours while enriching soil conditions without the damaging effects associated with chemical fertilizers. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being 100% environmentally friendly. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth in sales in the recent years.


Wall Street firm New York Global Securities, Inc. ("NYGS", provides research coverage for Bodisen. NYGS' parent company New York Global Group ( has a significant China presence and is one of the largest US firms in China in the financial services sector. London investment bank Charles Stanley (, a member of the London Stock Exchange since 1852, provides research coverage for Bodisen in London.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.


The Piacente Group, Inc.
Investor Relations:
Debra Chen, 212-481-1907
Source: Bodisen Biotech, Inc.


Copyright © 2004